Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Marcus E Randall
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
540 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inha University
Jung-gu, Incheon, South Korea
- Asan Medical Center
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Yongdong Severence Hospital
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Arizona Oncology Associates-West Orange Grove
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Kaiser Permanente - Sacramento
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Mercy General Hospital Radiation Oncology Center
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Mar 2009
- Primary completion
- 29 Dec 2014
- Completion
- —
- Last update posted
- 20 Mar 2019
- Registered enrollment
- 601
- Registry id
- NCT00807768
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.